Nanomedicine as an emerging platform for metastatic lung cancer therapy

D Landesman-Milo, S Ramishetti, D Peer - Cancer and Metastasis …, 2015 - Springer
Metastatic lung cancer is one of the most common cancers leading to mortality worldwide.
Current treatment includes chemo-and pathway-dependent therapy aiming at blocking the …

[HTML][HTML] Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment

P Czapiewski, M Kunc, J Haybaeck - Oncotarget, 2016 - ncbi.nlm.nih.gov
Olfactory neuroblastoma (ONB, Esthesioneuroblastoma) is an infrequent neoplasm of the
head and neck area derived from olfactory neuroepithelium. Despite relatively good …

Advances and implications in nanotechnology for lung cancer management

S Sarkar, K Osama… - Current drug …, 2017 - benthamdirect.com
Background: Lung cancer is one of the most fatal chronic diseases in the field of respiratory
medicine. The purpose of this paper is to address the side effects of conventional treatment …

Overcoming drug resistance with specific nano scales to targeted therapy: focused on metastatic cancers

WR Kadhum, AA Majeed, RO Saleh, E Ali… - … -Research and Practice, 2024 - Elsevier
Metastatic cancer, which accounts for the majority of cancer fatalities, is a difficult illness to
treat. Currently used cancer treatments include radiation therapy, chemotherapy, surgery …

Nanocomplex of Berberine with C60 Fullerene Is a Potent Suppressor of Lewis Lung Carcinoma Cells Invasion In Vitro and Metastatic Activity In Vivo

I Horak, S Prylutska, I Krysiuk, S Luhovskyi… - Materials, 2021 - mdpi.com
Effective targeting of metastasis is considered the main problem in cancer therapy. The
development of herbal alkaloid Berberine (Ber)-based anticancer drugs is limited due to …

Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation?

A Coca-Pelaz, KO Devaney, JP Rodrigo… - European Archives of …, 2016 - Springer
While small cell neuroendocrine carcinomas (SCNCs) most often arise in the lung,
extrapulmonary SCNCs arise in a variety of locations—including the head and neck region …

Small cell neuroendocrine carcinomas arising in the head and neck region

S Hosokawa, G Takahashi, S Baba, H Mineta - Journal of Oral and …, 2016 - Elsevier
Purpose This study evaluated the clinical factors associated with outcomes of head and
neck small cell neuroendocrine carcinoma (SCNEC-HN). Materials and Methods A …

[HTML][HTML] Immune reactivity and pseudoprogression or tumor flare in a serially biopsied neuroendocrine patient treated with the epigenetic agent RRx-001

CA Carter, B Schmitz, PG Peterson, M Quinn… - Case reports in …, 2016 - karger.com
Neuroendocrine tumors (NETs) are grouped together as a single class on the basis of
histologic appearance, immunoreactivity for the neuroendocrine markers chromogranin A …

A comparison of the outcomes of pulmonary versus extrapulmonary extensive‐stage small cell carcinoma

E Chen, PY Yip, A Tognela, G Gandy… - Internal Medicine …, 2024 - Wiley Online Library
Background Extrapulmonary small cell carcinomas (EPSCCs) are rare cancers, comprising
0.1–0.4% of all cancers. The scarcity of EPSCC studies has led current treatment strategies …

Rare case of metastatic small cell carcinoma of the nasopharynx to the pancreas

J Teinor, L Groshek, J He - BMJ Case Reports CP, 2020 - casereports.bmj.com
We present a 49-year-old woman with a history of an unresectable nasopharyngeal small
cell carcinoma (SCC) who was treated with concurrent chemotherapy and radiation therapy …